{
    "clinical_study": {
        "@rank": "47054", 
        "arm_group": {
            "arm_group_label": "755nm Alexandrite laser with lens array", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess treatment of facial acne scars using the 755nm\n      Alexandrite Laser with lens arrays."
        }, 
        "brief_title": "Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acne Scars", 
        "condition_browse": {
            "mesh_term": [
                "Acne Vulgaris", 
                "Cicatrix"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is a healthy male or female between 18 and 65 years old\n\n          2. Has unwanted acne scars, excluding ice pick scars (Deep atrophic scars that resemble\n             poked holes), and wishes to undergo laser treatments.\n\n          3. Is willing to consent to participate in the study.\n\n          4. Is willing to comply with all requirements of the study including biopsies, being\n             photographed, following post treatment care and attending all treatment and follow up\n             visits.\n\n        Exclusion Criteria:\n\n          1. The subject is female and pregnant, has been pregnant within the last 3 months, is\n             currently breast feeding or planning a pregnancy during the study period.\n\n          2. The subject is hypersensitive to light exposure OR takes photo sensitized medication.\n\n          3. The subject has active or localized systemic infections.\n\n          4. The subject has a coagulation disorder or is currently using anti-coagulation\n             medication (including but not limited to heavy aspirin therapy {greater than 81 mg\n             per day}).\n\n          5. The subject has any condition which, in the investigator's opinion, would make it\n             unsafe for the subject to participate in this research study.\n\n          6. The subject is currently enrolled in an investigational drug or device trial, or has\n             received an investigational drug or been treated with an investigational device\n             within 3 months prior to entering this study.\n\n          7. The subject has used Accutane within 6 months prior to enrollment.\n\n          8. The subject has the need to be exposed to artificial tanning devices or excessive\n             sunlight during the trial.\n\n          9. The subject has had prior treatment with parenteral gold therapy (gold sodium\n             thiomalate).\n\n         10. The subject has a history of keloids.\n\n         11. The subject has evidence of compromised wound healing.\n\n         12. The subject has a history of squamous cell carcinoma or melanoma.\n\n         13. The subject has a history of immunosuppression/immune deficiency disorders (including\n             HIV infection or AIDS) or use of immunosuppressive medications.\n\n         14. The subject has an allergy to lidocaine and epinephrine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103127", 
            "org_study_id": "CYN13-PCAP-AS-SK02"
        }, 
        "intervention": {
            "arm_group_label": "755nm Alexandrite laser with lens array", 
            "intervention_name": "755nm Alexandrite laser with lens array", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sacramento", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95816"
                }, 
                "name": "Laser & Skin Surgery Center of Northern California"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To compare severity post treatment using a grading scale for acne scars.", 
            "safety_issue": "No", 
            "time_frame": "3 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103127"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Investigator and subject will complete satisfaction questionnaire at follow up visits", 
            "measure": "Satisfaction Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "3 months post treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}